Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma

Oncogene

Volumn 18, Issue 9, 1999, Pages 1745-1753

  Gerbitz, A ^a   Mautner, J ^b   Geltinger, C ^c   Hortnagel K ^d   Christoph, B ^c   Asenbauer, H ^d   Klobeck, G ^d   Polack, A ^c   Bornkamm, G W ^c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Burkitt's lymphoma; c myc; Gene regulation; Lambda enhancer; Na Butyrate

Indexed keywords

IMMUNOGLOBULIN LAMBDA CHAIN;

ARTICLE; BURKITT LYMPHOMA; CHROMOSOME 14; CHROMOSOME 2; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 8; DEREGULATION; ENHANCER REGION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE;

EID: 0033522142     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202468     Document Type: Article

References (56)

1. Adams CC and Workman JL. (1993). Cell, 72, 305-308.
2. Anisimova E, Saemundsen AK, Roubal J, Vonka V and Klein G. (1982). J. Gen. Virol., 58, 163-171.
3. Aronow BJ, Ebert CA, Valerius MT, Potter SS, Wiginton DA, Witte DP and Hutton JJ. (1995). Mol. Cell. Biol., 15, 1123-1135.
4. Asenbauer H and Klobeck HG. (1996). Eur. J. Immunol., 26, 142-150.
5. Bergman Y, Rice D, Grosschedl R and Baltimore D. (1984). Proc. Acad. Natl. Sci. USA, 7041-7045.
6. Blasquez VC, Xu M, Moses SC and Garrard WT. (1989). J. Biol. Chem., 264, 211183-211189.
7. Blomberg B, Rudin CM and Storb U. (1991). J. Immunol., 147, 2354-2358.
8. Bornkamm GW, Polack A and Eick D. (1988). George Klein (ed). Marcel Dekker Inc., New York. pp. 223-273.
9. Breznick EH and Tze L. (1997). Proc. Natl Acad. Sci., 94, 4566-4571.
10. Burkitt DP. (1958). Br. J. Surg., 46, 218-223.
11. Combriato G and Klobeck HG. (1991). Eur. J. Immunol., 21, 1513-1519.
12. Cory S. (1986). Adv. Cancer Res., 47, 189-234.
13. Dalla-Favera R, Bregni M, Erikson J, Ratterson D, Gallo RC and Croce CM. (1982). Proc. Natl. Acad. Sci. USA, 79, 7824-7825.
14. de Wet JR, Wood KV, DeLuca M, Helinski DR and Subramani S. (1987). Mol. Cell Biol., 7, 725-737.
15. DesJardin E and Hay N. (1993). Mol. Cell. Biol., 13, 5710-5724.
16. Eick D and Bornkamm GW. (1986). Nucleic Acid Res., 14, 8331-8346.
17. Eick D and Bornkamm GW. (1989). EMBO J., 8, 1965-1972.
18. Felsenfeld G. (1992). Nature, 355, 219-224.
19. Forrester WC, Genderen CV, Jenuwein T and Grosschedl R. (1994). Science, 265, 1221-1225.
20. Geltinger C, Hörtnagel K and Polack A. (1996). Gene Expression, 6, 113-127.
21. Glozak MA and Blomberg BB. (1996). Mol. Immunol., 33, 427-438.
22. Gross DS and Garrard WT. (1988). Ann. Rev. Biochem., 57, 159-187.
23. Grosveld F, van Assendelft GB, Greaves DR and Kollias G. (1987). Cell, 51, 975-985.
24. Hartl P and Lipp M. (1987). Mol. Cell Biol., 7, 2037-2045.
25. Hayday AC, Gillies SD, Saito H, Wood C, Wimann K, Hayward WS and Tonegawa S. (1984). Nature, 307, 334-340.
26. Mollis GF, Mitchell KF, Battey J, Potter H, Taub R, Lenoir GM and Leder P. (1984). Nature, 307, 752-755.
27. Hörtnagel K, Mautner J, Strobl L, Wolf D, Christoph B, Geltinger C and Polack A. (1995). Oncogene, 10, 1393-1401.
28. Hug B, Moon A and Ley T. (1992). Nucleic Acid Res., 20, 5771-5778.
29. Joos S, Haluska FG, Falk MH, Henglein B, Hameister B, Croce CM and Bornkamm GW. (1992). Cancer Res., 52, 6547-6552.
30. Klehr D, Maass K and Bode J. (1991). Biochemistry, 30, 1264-1270.
31. Korsmeyer SJ. (1992). Annu. Rev. Immunol., 10, 785-807.
32. Lee DY, Hayes JJ, Pruss D and Wolffe AP. (1993). Cell, 72, 73-84.
33. Look T. (1997). Science, 278, 1059-1064.
34. Madisen L and Groudine M. (1994). Genes Dev., 8, 2212-2226.
35. Magrath I. (1990). Adv. Cancer Res., 55, 134-270.
36. Mautner J, Joos S, Werner T, Eick D, Bornkamm GW and Polack A. (1995). Nucleic Acid Res., 23, 72-80.
37. Mautner J, Behrends U, Hörtnagel K, Brielmeier M, Hammerschmidt W, Strobl L, Bornkamm GW and Polack A. (1996). Oncogene, 12, 1299-1307.
38. Nowell PC and Hungerford DA. (1960). Science, 132, 1497.
39. Nowell PC and Croce CM and Philip Levine Award Lecture. (1990). Am. J. Clin. Pathol., 94, 229-237.
40. Polack A, Eick D, Koch E and Bornkamm GW. (1987). EMBO J., 6, 2959-2964.
41. Polack A, Strobl L, Feederle R, Schweizer M, Koch E and Bornkamm GW. (1991). Oncogene, 6, 2033-2040.
42. Polack A, Feederle R, Klobeck G and Hörtnagel K. (1993). EMBO J., 12, 3913-3920.
43. Pulvertaft RJV. (1964). Lancet 1, 238-240.
44. Queen C and Stafford J. (1984). Mol. Cell. Biol., 4, 1042-1049.
45. Rabbitts TH, Forster A, Baer R and Hamlyn PH. (1983). Nature, 306, 806-809.
46. Rabbitts TH. (1994). Nature, 372, 143-149.
47. Rottleb C, Bornkamm GW and Polack A. (1995). Int. J. Cancer, 62, 697-702.
48. Rottleb C, Bornkamm GW and Polack A. (1996). Int. J. Cancer, 67, 1-6.
49. Sambrook J, Fritsch EF and Maniatis T. (1989). Cold Spring Harbor Laboratory Press.
50. Showe LC, Moore RC, Erikson J and Croce CM. (1987). Proc. Natl. Acad. Sci. USA, 84, 2824-2828.
51. Solomon E, Borrow J and Goddard AD. (1991). Science, 254, 1153-1160.
52. Stief A, Winter DM, Stratling WH and Sippel AE. (1989). Nature, 341, 341-345.
53. Strobl L, Kohlhuber F, Mautner J, Polack A and Eick D. (1993). Oncogene, 8, 1437-1447.
54. Sugden B, Marsh K and Yates J. (1985). Mol. Cell Biol., 5, 410-413.
55. Zeidler R, Joos S, Delecluse H, Klobeck G, Vuillaume M, Lenoir GM, Bornkamm GW and Lipp M. (1994). Genes Chrom. Cancer, 9, 282-287.
56. Zimber-Strobl U, Strobl L, Kremmer E, Graesser F, Marschall G, Laux G and Bornkamm GW. (1993). EMBO J., 12, 167-175.